Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma
about
Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing.Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible FactorCirculating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell linesExpression of vascular endothelial growth factor in Ewing's sarcoma.Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.Immunohistochemical expression of vegf and her-2 proteins in osteosarcoma biopsies.How can survival be improved in localized osteosarcoma?Review of management issues in relapsed osteosarcoma.Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with different phases of osteosarcoma.Protein kinase C epsilon and genetic networks in osteosarcoma metastasis.Tumor angiogenesis and outcome in osteosarcoma.Retrospective investigation of "paint brush borders" sign in association with local recurrence of giant cell tumor of bone after intralesional curettage.A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma.Imaging of highly malignant osteosarcoma with iodine-123-vascular endothelial growth factor.
P2860
Q33273835-0A5E427A-E520-45D5-B7D0-B87C8FCA434BQ33531554-AF857AA5-08B2-4EF7-8B86-B3E798C29C4CQ33624977-D262EC2B-ADB6-42D7-93E0-A29D45DE3623Q33634602-3027DC06-964A-4F47-8AF3-BFCB6F797CF9Q34762886-2800A5CC-AC4F-470D-AFE0-B0B241CF82E1Q36341778-3E2F7483-8FBF-42E4-83E9-BCC2F92B66E9Q36438319-24B1DD57-4143-4CAF-81D8-4EC929CC6F2DQ36502150-B14BE467-A2F2-4D33-8B8B-DAA2C9638AC3Q36731426-FE47C77B-8B1C-4224-9C8E-A44D0405BF6FQ37389600-0C2DF569-5B83-47F5-BA33-704602BE5F93Q37782098-5B1A6694-3C85-4570-8F5B-8FE72C326FEAQ38168922-6A84E97E-7D7F-4A67-9934-5E63E9D73F99Q39177327-CC4693A0-1BF7-47D7-AE61-8CF94290FB73Q40593958-6B698FD3-FBE8-4DF2-B8C8-470FD4EB793CQ41550671-A03198AE-A74C-4388-B126-6A799DFD39F7Q42265507-1D19050E-DC39-44B5-964F-CD7B26A238F7Q45176486-A4CFB259-EE7F-48BB-B40A-5832BB391CE8Q47150814-8C0CBD6A-3679-4D62-A84C-5F984D6B0B66Q48252313-CBF2D25B-CC53-4487-A73A-2C5B96A7D875Q48344163-2C76F728-2E95-48B6-BEC4-E6D7BB04C2CCQ51330391-63A57498-638C-4E7A-8DB6-175C529B716F
P2860
Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Increased pre-therapeutic seru ...... inical relapse of osteosarcoma
@ast
Increased pre-therapeutic seru ...... inical relapse of osteosarcoma
@en
type
label
Increased pre-therapeutic seru ...... inical relapse of osteosarcoma
@ast
Increased pre-therapeutic seru ...... inical relapse of osteosarcoma
@en
prefLabel
Increased pre-therapeutic seru ...... inical relapse of osteosarcoma
@ast
Increased pre-therapeutic seru ...... inical relapse of osteosarcoma
@en
P2093
P2860
P356
P1476
Increased pre-therapeutic seru ...... inical relapse of osteosarcoma
@en
P2093
F Higashino
S Kawaguchi
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600201
P407
P577
2002-03-01T00:00:00Z
P5875
P6179
1022101393